強気
$0.73
シナリオ価格
$2.090
+0.105 (+5.03%)終値時点
So-Young International Inc is a holding company mainly engaged in online platform for discovering, evaluating and reserving medical aesthetic services. The Company operates its businesses through two segments including So-Young segment and Wuhan Miracle segment. So-Young segment mainly provides information services, reservation services, aesthetic treatment services and sales of medical products and maintenance services. Wuhan Miracle segment is mainly engaged in the research and development, production, sales and agency of laser and other optoelectronic medical equipment. The Company operates across multiple access points, including mobile app, Weixin mini program, and soyoung.com website.
So-Young International Inc is not a good buy right now due to its current price of 1.99, which is significantly below its 52-week high of 4.75, and an RSI of 12.45 indicating it is oversold. While the company has shown revenue growth, with Q2 2026 revenue at 505.2 million CNY, a 33% year-over-year increase, it still faces significant net losses, with a net income of -22.7 million CNY in Q2 2026. The main risk is its negative earnings per share of -0.29, which reflects ongoing financial challenges despite some positive revenue trends.
シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

So-Young International Reports Record Q2 Revenue Growth

So-Young International Reports Strong Q2 2026 Financial Results

So-Young International Reports Strong Q2 2026 Financial Results

So-Young International to Report Q2 2026 Financial Results

So-Young International Appoints New CFO
So-Young International Inc is a holding company mainly engaged in online platform for discovering, evaluating and reserving medical aesthetic services. The Company operates its businesses through two segments including So-Young segment and Wuhan Miracle segment. So-Young segment mainly provides information services, reservation services, aesthetic treatment services and sales of medical products and maintenance services. Wuhan Miracle segment is mainly engaged in the research and development, production, sales and agency of laser and other optoelectronic medical equipment. The Company operates across multiple access points, including mobile app, Weixin mini program, and soyoung.com website. It operates in the Consumer Cyclicals sector (COMPUTER PROCESSING AND DATA PREPARATION AND PROCE industry).
So-Young International Inc is not a good buy right now due to its current price of 1.99, which is significantly below its 52-week high of 4.75, and an RSI of 12.45 indicating it is oversold. While the company has shown revenue growth, with Q2 2026 revenue at 505.2 million CNY, a 33% year-over-year increase, it still faces significant net losses, with a net income of -22.7 million CNY in Q2 2026. The main risk is its negative earnings per share of -0.29, which reflects ongoing financial challenges despite some positive revenue trends.
投稿はまだありません
登録またはログインして議論に参加本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。